Bamlanivimab

**Semantic type:** Amino Acid, Peptide, or Protein|Immunologic Factor|Pharmacologic Substance

**Definition:** A neutralizing immunoglobulin G1 (IgG1) monoclonal antibody directed against the spike protein (SP) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for immunization against COVID-19. Upon administration of bamlanivimab, this agent specifically targets and binds to the SP, thereby blocking viral attachment and entry into human cells and may thereby neutralize SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may potentially provide temporary protection against infection with SARS-CoV-2.

**Synonyms:** - BAMLANIVIMAB - LY 3819253 - LY CoV555 - LY-3819253 - LY-CoV55 - LY3819253 - LYCoV555 - Monoclonal antibodies against SARS-CoV-2: bamlanivimab